posted on 2005-05-04, 00:00authored byYahel Vakrat-Haglili, Lev Weiner, Vlad Brumfeld, Alexander Brandis, Yoram Salomon, Brian Mcllroy, Brian C. Wilson, Anna Pawlak, Malgorzata Rozanowska, Tadeusz Sarna, Avigdor Scherz
Generation of reactive oxygen species (ROS) is the hallmark of important biological processes
and photodynamic therapy (PDT), where ROS production results from in situ illumination of certain dyes.
Here we test the hypothesis that the yield, fate, and efficacy of the species evolved highly depend on the
dye's environment. We show that Pd−bacteriopheophorbide (Pd−Bpheid), a useful reagent for vascular
targeted PDT (VTP) of solid tumors, which has recently entered into phase II clinical trials under the code
name WST09 (trade name TOOKAD), forms appreciable amounts of hydroxyl radicals, superoxide radicals,
and probably hydrogen peroxide in aqueous medium but not in organic solvents where singlet oxygen
almost exclusively forms. Evidence is provided by pico- and nanosecond time-resolved spectroscopies,
ESR spectroscopy with spin-traps, time-resolved singlet oxygen phosphorescence, and chemical product
analysis. The quantum yield for singlet oxygen formation falls from ∼1 in organic solvents to ∼0.5 in membrane-like systems (micelles or liposomes), where superoxide and hydroxyl radicals form at a minimal
quantum yield of 0.1%. Analysis of photochemical products suggests that the formation of oxygen radicals
involves both electron and proton transfer from 3Pd−Bpheid at the membrane/water interface to a colliding
oxygen molecule, consequently forming superoxide, then hydrogen peroxide, and finally hydroxyl radicals,
with no need for metal catalysis. The ability of bacteriochlorophyll (Bchl) derivatives to form such radicals
upon excitation at the near infrared (NIR) domain opens new avenues in PDT and research of redox
regulation in animals and plants.